Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CBSTF | Common Shares | Sale | -$17K | -50K | -0.24% | $0.34 | 21.1M | Nov 28, 2023 | Held by Vita Holdings LLC | F1, F5 |
transaction | CBSTF | Common Shares | Sale | -$33K | -100K | -0.47% | $0.33 | 21M | Nov 28, 2023 | Held by Vita Holdings LLC | F2, F5 |
transaction | CBSTF | Common Shares | Sale | -$17K | -50K | -0.24% | $0.34 | 21M | Nov 29, 2023 | Held by Vita Holdings LLC | F3, F5 |
transaction | CBSTF | Common Shares | Sale | -$17K | -50K | -0.24% | $0.34 | 20.9M | Nov 29, 2023 | Held by Vita Holdings LLC | F4, F5 |
holding | CBSTF | Common Shares | 619K | Nov 28, 2023 | Direct |
Id | Content |
---|---|
F1 | The sales price reported above was converted from the Canadian sales price of C$0.465 using an exchange rate of C$1.3581 = US$1.00. |
F2 | The sales price reported above was converted from the Canadian sales price of C$0.45 using an exchange rate of C$1.3581 = US$1.00. |
F3 | The sales price reported above was converted from the Canadian sales price of C$0.46 using an exchange rate of C$1.3590 = US$1.00. |
F4 | The sales price reported above was converted from the Canadian sales price of C$0.465 using an exchange rate of C$1.3590 = US$1.00. |
F5 | Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, educational and philanthropic purposes. |